Year: 2025
Type: article
Study design: Clinical Trial
Abstract: INTRODUCTION: Nonsurgical rhinoplasty or rhinomodelation is a sought-after procedure in aesthetic practice. The current product of choice remains hyaluronic acid (HA) because of its ease of use and reversibility. However, it does carry some risks. Polycaprolactone (PCL) fillers hold a lot of promise in aesthetic practice. It has an established safety profile and a longer duration of action. Because of its unique properties, it may hold the key to the future of nonsurgical rhinomodelation. METHODS: Twelve patients were enrolled in the study. Ten out of these were not willing to ask for surgery and had no breathing problems. Two were post-surgical rhinoplasty complications who did not want another surgery. 0.2 mL of PCL filler was injected at each site according to the need (radix, spine, and or tip). The Global Aesthetic Improvement Scale (GAIS; 3 = very much improved, 2 = considerably improved, 1 = improved, 0 = no change, and -1 = worse) was used along with a patient satisfaction scale (highly satisfied, satisfied, dissatisfied) were used. The sum of the GAIS ratings was quantified as total improvement (TMI). The patients were followed up for 12 months before and 12 months after procedures were taken and documented. RESULTS: The GAIS score was 98% for the study and all patients were highly satisfied with their treatment right after procedure and 12 months later. CONCLUSION: PCL fillers may be the way forward for long-term sustained results in nonsurgical rhinomodelation. Expert injection techniques and knowing the side effects and handling them is mandatory.
Source: Journal of Cosmetic Dermatology
DOI: 10.1111/jocd.70001
Authors: Kamran Izhar Qureshi, Franco Vercesi, Hina Farooq Qureshi
Institution: Institute of Management Sciences Lahore
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,020
OpenAlex ID: W4407238240